Benefits of an enhanced-depth-of-focus intraocular lens to aspheric IOLs vs optical quality and visual side effect comparison: are monofocal IOLs still standard of care?

Session Details

Session Title: Moderated Poster Session: EDOF vs Multifocal IOLs

Venue: Poster Village: Pod 1

First Author: : F.Kretz GERMANY

Co Author(s): :    D. Breyer   D. Holland   S. Abdassalam   I. Tarib   M. Gerl   G. Auffarth        

Abstract Details

Purpose:

The aim of this study was the comparison of functional and refractive results, defocus curve, disphotopic phenomena and questionnaire results in patients binocularly implanted with either an enhanced depth of focus (EDOF) intraocular lens (IOL) (Oculentis Comfort, Oculentis Germany) and an aspheric IOL (CT Asphina 409, Carl Zeiss Meditech, Germany).

Setting:

Augenärzte Gerl, Kretz & Kollegen, Rheine, Germany member & Breyer - Kaymak - Klabe Augenchirurgie, Düsseldorf & Nordblick GmbH, Kiel, Germany & Univ. ophthalmology hospital, Heidelberg, Germany members of the International Vision Correction Research Centre Network (IVCRC.net), Dept. of Ophthalmology, Univ. of Heidelberg, Germany

Methods:

In a prospective clinical trial patients binocularly implanted with either an EDOF IOL or an aspheric IOL targeted emmetropia were included 3-9 month after uncomplicated cataract surgery. Refractive outcome, functional results (UDVA, CDVA, DCIVA), Defocus curve, HD Analyzer, Halo & Glare Simulator and subjective questionnaire results for both groups were evaluated.

Results:

Mean spherical equivalent showed no significant difference in both groups. The EDOF group showed a higher depth of focus in the defocus curve analysis compared to the aspheric IOL group. The Halo & Glare assessment showed an equal distribution of Halo and Glare strength in both groups with actually less strength in the EDOF IOL group of patients. Optical quality evaluation with the HD Analyzer showed a similar optical quality of both IOL groups.

Conclusions:

The rotational asymmetric design of EDOF IOL shows similar to less disphotopic phenomena incidence to the aspheric IOL group with a comparable optical quality while still offering patients a wider range of vision.

Financial Disclosure:

has significant investment interest in a company producing, developing or supplying product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non-monetary benefits from a competing company., receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented., receives consulting fees, retainer, or contract payments from a competing company, receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, has significant investment interest in a competing company